Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/17/19
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 01/31/24
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 06/15/25
End: 03/13/26
Due: 03/13/27
Phase: N/A
Priority: Normal
Start: 06/19/24
End: 08/01/25
Due: 08/01/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety Study of AZT-04 for Cosmetic Use | NCT03820076 | Azitra Inc. | user2@example.com | None | 2019-01-17 | 2019-07-31 | 2020-07-31 | - | - | 2025-07-14 |
| Study to Evaluate the Safety of ATR-04 | NCT04731259 | Azitra Inc. | user2@example.com | None | 2024-01-31 | 2026-01-31 | 2027-01-31 | - | - | 2025-07-14 |
| A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity | NCT06830863 | Azitra Inc. | user2@example.com | None | 2025-06-15 | 2026-03-13 | 2027-03-13 | - | - | 2025-07-14 |
| Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome | NCT06137157 | Azitra Inc. | user2@example.com | None | 2024-06-19 | 2025-08-01 | 2026-08-01 | - | - | 2025-07-14 |